The present invention is related to a new method for the synthesis of alpha-aminoalkylenephosphonic acid or its phosphonate esters comprising the steps of forming a reaction mixture by mixing a POP anhydride moiety comprising compound, having one P-atom at the oxidation state (+III) and the other P-atom at the oxidation state (+III) or (+V), an aminoalkanecarboxylic acid and an acid catalyst, wherein said reaction mixture comprises an equivalent ratio of alpha-aminoalkylene carboxylic acid to POP anhydride moieties of at least 0.2, and recovering the resulting alpha-aminoalkylene phosphonic acid compound or an ester thereof from the reaction mixture.

Dendrimers with monophosphonic or bisphosphonic terminations for the treatment of inflammatory diseases.

Oral dosage forms of osteoclast inhibitors, such as zoledronic acid, in an acid or a salt form, can be used to treat or alleviate pain or related conditions, such as arthritis.

The present invention relates to phosphonate compounds, compositions containing them, processes for obtaining them, and their use for treating a variety of medical disorders, e.g., osteoporosis and other disorders of bone metabolism, cancer, viral infections, and the like.

Multi-acid polymers for use as a fuel cell membrane, for example, have multi-acid monomers that have an imide base and more than two proton conducting groups. The multi-acid polymers are made by reacting a polymer precursor in sulfonyl fluoride or sulfonyl chloride form with a compound with an acid giving group. One example of a multi-acid polymer is: ##STR00001##
wherein R is one or more units of a non-SO.sub.2F or non-SO.sub.2Cl portion of a polymer precursor in sulfonyl fluoride or sulfonyl chloride form.

The present disclosure is directed to fatty-acid glycerol ester derivative compounds containing a targeting bisphosphonate group. The disclosure further include pharmaceutical or biomedical compositions comprising these compounds, and methods of using these compounds and compositions forming microbubbles. The microbubbles have affinity for metal-containing, especially calcium-containing, bodies and/or biological targets. In certain embodiments, these compositions are useful for providing targeted placement of microbubbles capable of cavitation on application of high frequency energy.

The present disclosure provides a pressure-reducing and injection-enhancing anti-scaling agent for low-permeability water-injection wells and a preparation method thereof The anti-scaling agent is prepared from starting materials comprising: 10 to 12 parts of non-ionic surfactant(s), 18 to 20 parts of hexasodium triethylenetetramine-N,N,N,N,N,N-hexaacetate, 5 to 8 parts of anionic surfactant(s), 6 to 8 parts of an organic phosphonic acid-carboxylic acid scale inhibitor, 2 to 5 parts of a dispersant, 15 to 18 parts of a diluent, 8 to 10 parts of an organic amine salt, and 30 to 36 parts of water. The pressure-reducing and injection-enhancing agent according to the present disclosure is characterized by having multiple functions in one agent. When used in an amount being 0.5% of the water injected to a water injection well, it shows excellent anti-swelling property, shrinking property, anti-corrosive property, and calcium sulfate and barium (strontium) sulfate scale resistance.

The present invention relates to conjugate compounds and methods of making and using same.

Oral dosage forms of osteoclast inhibitors, such as zoledronic acid, in an acid or a salt form can be used to treat or alleviate pain or related conditions, such as complex regional pain syndrome.

A compound or a polymer is claimed. A first formula can be

##STR00001##

wherein X is H, CH.sub.3, CN, phenyl, substituted phenyl, (CH.sub.2).sub.mZ, or phenyl(CH.sub.2).sub.mZ; T is O, N, S or NH; m equals 1 to 20; n equals 1-100; and Z is CN, NH.sub.2, Thiol, OH, or CO.sub.2H. The second formula is:

##STR00002##

wherein X is H, CH.sub.3, CN, phenyl, substituted phenyl, (CH.sub.2).sub.mZ, or phenyl(CH.sub.2).sub.mZ; and Z is CN, NH.sub.2, Thiol, OH, or CO.sub.2H. The third formula is

##STR00003##

wherein: R.sub.1, R.sub.2, R.sub.3, and R.sub.4 are independently: H, CH.sub.3, OH, or a halogen.